Premium skincare and MedTech brands invest years in clinical research, proprietary formulations, and independently validated results. The science is there. The product page rarely reflects it.
I identify exactly where clinical credibility is absent, buried, or mistranslated in the customer journey — and what that gap is costing in revenue.
Across premium skincare and MedTech, the same pattern appears. A brand with serious clinical credibility — peer-reviewed mechanisms, proprietary formulations, independently validated results — communicates as if none of it exists.
The clinical evidence stays in the white papers. The product page says "transformative" and hopes for the best.
The buyer who would most respond to the science never encounters it in a form she can understand, trust, and act on.
The biological explanation of why the product works lives in an accordion, a separate page, or nowhere at all. The buyer who most needs to understand it never encounters it.
Clinical proof appears after the purchase decision has already been made. The buyer who needs convincing has already left the page.
Technical language without context, vague benefit language without evidence. Neither converts the ingredient-literate buyer the brand is trying to reach.
Every engagement begins with the science — not the page. Before assessing whether a mechanism is communicated clearly, I assess whether it is clinically defensible. Before recommending a change, I understand what the product can credibly claim and who needs to hear it.
A deep assessment of your hero product page — or any page losing conversions. Covers hero clarity, claim architecture, mechanism explanation, trust signal placement, and page flow. Delivered as a designed report with specific findings, rewrite examples for the highest-leverage elements, and a revenue impact hypothesis quantifying what the changes are worth annually. Every recommendation is specific enough to act on the day you receive it.
You come in before the page is built. I read the formulation science, assess what can be credibly claimed, structure the proof architecture, and ensure the clinical communication is built correctly from day one — before it goes live, not after it has been losing conversions for six months.
An ongoing monthly partnership covering new product pages, campaigns, and launches as they happen. New formulations, new claims, new markets — each one assessed for clinical defensibility and conversion architecture before it reaches the buyer. For brands where clinical communication is continuous operational work, not a one-time fix.
Premium skincare and MedTech brands with peer-reviewed mechanisms, proprietary formulations, and independently validated results — where the product page does not reflect the depth of the science behind it.
Brands who want the clinical communication architecture built correctly from the start rather than corrected six months after launch, once the cost of getting it wrong has already been paid.
Founders and CMOs who know their conversion rate should be higher given the product quality — and suspect the problem is how the product is understood at the moment of purchase, not how many people are arriving.
Their strongest competitive argument — retinal converts to retinoic acid 11x faster than retinol — was absent from the product page entirely. It lived on a separate educational page most buyers never reach.
The page asked visitors to choose a strength and add to bag before showing them why Crystal Retinal outperforms the retinol they already use. The mechanism that would have converted the sceptical informed buyer was treated as background reading.
Download case study →My scientific training began with a deep curiosity about the human body — how biological systems function, how cells repair themselves, and what determines aging, health, and longevity. Studying genetics and bioengineering wasn't a detour from what I do now. It was the foundation of it.
Across biotechnology, medical technology, and advanced skincare, I kept noticing the same gap. The most sophisticated and evidence-backed products struggled to gain trust and adoption. The science was there — clinical mechanisms, molecular pathways, independently validated results. The communication wasn't. The people who would most respond to the evidence rarely encountered it in a form they could understand, trust, and act on.
That gap is what led me to pursue an MSc in Global Marketing at the University of York — not to move away from science, but to develop the strategic and communication skills to bridge it. Before I open a product page, I read the formulation science. Before I assess whether a mechanism is communicated clearly, I assess whether it is clinically defensible.
My long-term focus is the same question it has always been: how do we ensure that the most meaningful advances in human health, longevity, and wellness do not stay confined to laboratories or clinical papers — but actually reach the people they were created for.
If you would like to know what I would find on your product page, I would be glad to take a look. A 20-minute conversation is usually enough to identify whether there is something worth investigating.
Get in touch →